bromocriptine has been researched along with methylnitronitrosoguanidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Iishi, H; Okuda, S; Taniguchi, H; Tatsuta, M | 1 |
| Baba, M; Ichii, M; Iishi, H; Nakaizumi, A; Taniguchi, H; Tatsuta, M; Uehara, H | 1 |
| Inoue, K; Maekawa, A; Nishikawa, A; Suzuki, T; Takahashi, M; Taya, K; Watanabe, G; Yoshida, M | 1 |
3 other study(ies) available for bromocriptine and methylnitronitrosoguanidine
| Article | Year |
|---|---|
Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adenocarcinoma; Animals; Bromocriptine; Dopamine; Epinephrine; Gastric Mucosa; Gastrins; Hydrogen-Ion Concentration; Male; Methylnitronitrosoguanidine; Neoplasms, Experimental; Norepinephrine; Rats; Rats, Inbred Strains; Stomach Neoplasms | 1992 |
Attenuating effect of bromocriptine on cysteamine anticarcinogenesis of stomach cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine.
Topics: Animals; Bromocriptine; Cysteamine; Drug Interactions; Gastric Acid; Gastric Mucosa; Gastrins; Male; Methylnitronitrosoguanidine; Mitotic Index; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values; Stomach Neoplasms | 1990 |
Long-term treatment with bromocriptine inhibits endometrial adenocarcinoma development in rats.
Topics: Adenocarcinoma; Animals; Bromocriptine; Carcinogens; Endometrial Neoplasms; Estradiol; Female; Follicle Stimulating Hormone; Histocytochemistry; Hormone Antagonists; Inhibins; Luteinizing Hormone; Methylnitronitrosoguanidine; Progesterone; Prolactin; Rats | 2009 |